CULVERWELL ANTHONY JAMES enters QUOIN PHARMACEUTICALS, LTD. with 19.07M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/3/2023ACC: 0001104659-23-000135
Director
Since Feb 2026
19.07M
Baseline shares
100% direct
19.07M
Direct ownership
1 position
64.29M
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned19.07M
Total
19.07M direct19.07M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 19.07M | Direct |
| Total | 19.07M | 19.07M direct |
Derivative Holdings1
Share Option (right to buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
64.29M
Shares owned
N/A
Exercise price
0.0035
Expiration
—
Exercise window
—
Total
Underlying
64.29M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Share Option (right to buy) Direct | Ordinary Shares | 0.0035 | — | — | 64.29M | N/A |
| Total | 64.29M | 0.00 | ||||